JPMorgan Starts Amrize Ltd (AMRZ) at Overweight

July 15, 2025 12:59 AM EDT Send to a Friend
JPMorgan analyst Adrian Huerta initiates coverage on Amrize Ltd (NYSE: AMRZ) with a Overweight rating and a price target of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login